These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 23861327

  • 1. Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.
    Pita Lobo P, Coelho M, Mestre TA, Rosa MM, Ferreira JJ.
    Mov Disord; 2013 Aug; 28(9):1212-4. PubMed ID: 23861327
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hemiparkinsonism and levodopa-induced dyskinesias following focal nigral lesion.
    Alves R, Barbosa E, Scaff M.
    Mov Disord; 2006 Dec; 21(12):2267-8; author reply 2268. PubMed ID: 17078068
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Levodopa-responsive parkinsonism-dystonia due to a traumatic injury of the substantia nigra].
    Pérez Errazquin F, Gomez Heredia MJ.
    Neurologia; 2012 Apr; 27(3):181-3. PubMed ID: 21570743
    [No Abstract] [Full Text] [Related]

  • 9. Choreiform dyskinesias following levodopa treatment of parkinsonism due to osmotic demyelination syndrome.
    de Souza A, de Souza RJ.
    Parkinsonism Relat Disord; 2017 Oct; 43():120-121. PubMed ID: 28729089
    [No Abstract] [Full Text] [Related]

  • 10. Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra.
    Ohta K, Obara K.
    Mov Disord; 2006 Jan; 21(1):124-5. PubMed ID: 16229001
    [No Abstract] [Full Text] [Related]

  • 11. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.
    Guigoni C, Dovero S, Aubert I, Li Q, Bioulac BH, Bloch B, Gurevich EV, Gross CE, Bezard E.
    Eur J Neurosci; 2005 Jul; 22(1):283-7. PubMed ID: 16029219
    [Abstract] [Full Text] [Related]

  • 12. The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies.
    Astradsson A, Jenkins BG, Choi JK, Hallett PJ, Levesque MA, McDowell JS, Brownell AL, Spealman RD, Isacson O.
    Neurobiol Dis; 2009 Sep; 35(3):348-51. PubMed ID: 19501164
    [Abstract] [Full Text] [Related]

  • 13. Levodopa-induced dyskinesia in a patient who has normal presynaptic dopaminergic neurons.
    Sunwoo MK, Kim KM, Hong JY, Sohn YH, Lee PH.
    Mov Disord; 2013 Jul; 28(8):1152-3. PubMed ID: 23386570
    [No Abstract] [Full Text] [Related]

  • 14. Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra.
    Kivi A, Trottenberg T, Kupsch A, Plotkin M, Felix R, Niehaus L.
    Mov Disord; 2005 Feb; 20(2):258-60. PubMed ID: 15551348
    [No Abstract] [Full Text] [Related]

  • 15. Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: reduced synthesis or increased catabolism?
    Sancesario G, Morrone LA, D'Angelo V, Castelli V, Ferrazzoli D, Sica F, Martorana A, Sorge R, Cavaliere F, Bernardi G, Giorgi M.
    Neurochem Int; 2014 Dec; 79():44-56. PubMed ID: 25452081
    [Abstract] [Full Text] [Related]

  • 16. l-Dopa-free learned dyskinetic behavior in a Parkinson's primate model.
    Li Q, Fernagut PO, Bezard E.
    Mov Disord; 2019 Aug; 34(8):1237. PubMed ID: 31083822
    [No Abstract] [Full Text] [Related]

  • 17. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
    Cerasa A, Salsone M, Morelli M, Pugliese P, Arabia G, Gioia CM, Novellino F, Quattrone A.
    Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
    [Abstract] [Full Text] [Related]

  • 18. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.
    Aubert I, Guigoni C, Håkansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E.
    Ann Neurol; 2005 Jan; 57(1):17-26. PubMed ID: 15514976
    [Abstract] [Full Text] [Related]

  • 19. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy.
    Kobylecki C, Silverdale MA, Varma A, Dick JP, Kellett MW.
    Mov Disord; 2009 Dec 15; 24(16):2441-2. PubMed ID: 19908326
    [No Abstract] [Full Text] [Related]

  • 20. Metabotropic glutamate receptor II in the brains of Parkinsonian patients.
    Samadi P, Rajput A, Calon F, Grégoire L, Hornykiewicz O, Rajput AH, Di Paolo T.
    J Neuropathol Exp Neurol; 2009 Apr 15; 68(4):374-82. PubMed ID: 19287314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.